DOI: https://doi.org/10.22263/2312-4156.2021.3.25
Pashinskaya E.S.
The effect of toxoplasmas on the changes in the expression of BIRC5, ERBB-2/HER2-NEU, GLI, VEGF protooncogenes and the anti-oncogene TP53 in rats in the experiment
Vitebsk State Order of Peoples’ Friendship Medical University, Vitebsk, Republic of Belarus
Vestnik VGMU. 2021;20(3):25-33.
Abstract.
Objectives. To study the effect of toxoplasmas on the changes in the expression of protooncogenes BIRC5, ERBB-2/HER2-NEU, GLI, VEGF and the anti-oncogene TP53 in rats in an experiment depending on the infection dose and the period of parasite development.
Material and methods.The experiment was conducted on female Wistar rats to determine changes in the expression of the protooncogenes survivin (BIRC5), epidermal growth factor (ErbB-2/HER2-Neu), GLI 1, vascular endothelial growth factor (VEGF) and the anti-oncogene TP53 in comparison with the reference genes β-actin (ACTB) and GAPDH by means of PCR analysis in the tissues of 10 healthy and 120 animals invaded at different doses.
Statistical comparison of the results of all groups was drawn with the data of the «control» series (healthy animals, biopsies of the lungs, liver, spleen, brain). The results obtained in the experimental groups were as follows: the infection dose of 25 toxoplasma tachyzoites per 1 g of the animal body weight (5000 tachyzoites per female) and the infection dose of 50 toxoplasma tachyzoites per 1 g of the animal body weight (10000 tachyzoites per female), then they were also compared with each other.
Statistical processing of the obtained data was carried out using the program Statistica 10.0. The differences were considered to be reliable at a significance level of less than 0.05 (p<0.05).
Results. Toxoplasma was found to cause an infection dose-dependent increase in the expression of the protooncogenes survivin (BIRC5), epidermal growth factor (ErbB-2/HER2-Neu), GLI, vascular endothelial growth factor (VEGF) and a change in the strength expression of the anti-oncogene TP53 at all stages of the parasite development.
Conclusions. Experimental toxoplasmosis alters the expression of the protooncogenes survivin (BIRC5), epidermal growth factor (ErbB-2/HER2-Neu), GLI, vascular endothelial growth factor (VEGF), and the anti-oncogene TP53 in the tissues of the intermediate host.
Key words: toxoplasma, BIRC5, ErbB-2/HER2-Neu, GLI, VEGF, TP53, rat.
References
1. Wilne S, Collier J, Kennedy C, Koller K, Grundy R, Walker D. Presentation of childhood CNS tumours: a systematic review and meta-analysis. Lancet Oncol. 2007 Aug;8(8):685-95. doi: http://dx.doi.org/10.1016/S1470-2045(07)70207-3
2. Rutkowski S. Timely identification of suspected paediatric CNS tumours. Lancet Oncol. 2007 Aug;8(8):664. doi: http://dx.doi.org/10.1016/S1470-2045(07)70212-7
3. Goldman RD, Cheng S, Cochrane DD. Improving diagnosis of pediatric central nervous system tumours: aiming for early detection. CMAJ. 2017 Mar;189(12):E459-E463. doi: http://dx.doi.org/10.1503/cmaj.160074
4. Evans DGR, Salvador H, Chang VY, Erez A, Voss SD, Schneider KW, et al. Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res. 2017 Jun;23(12):e46-e53. doi: http://dx.doi.org/10.1158/1078-0432.CCR-17-0589
5. Langston ME, Bhalla A, Alderete JF, Nevin RL, Pakpahan R, Hansen J, et al. Trichomonas vaginalis infection and prostate-specific antigen concentration: Insights into prostate involvement and prostate disease risk. Prostate. 2019 Oct;79(14):1622-1628. doi: http://dx.doi.org/10.1002/pros.23886
6. Han I-H, Kim J-H, Jang K-S, Ryu J-S. Inflammatory mediators of prostate epithelial cells stimulated with Trichomonas vaginalis promote proliferative and invasive properties of prostate cancer. Prostate. 2019 Jul;79(10):1133-1146. doi: http://dx.doi.org/10.1002/pros.23826
7. Yang S, Zhao W, Wang H, Wang Y, Li J, Wu X. Trichomonas vaginalis infection-associated risk of cervical cancer: A meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2018 Sep;228:166-173. doi: http://dx.doi.org/10.1016/j.ejogrb.2018.06.031
8. Berahmat R, Mahami-Oskouei M, Rezamand A, Spotin A, Aminisani N, Ghoyounchi R, et al. Cryptosporidium infection in children with cancer undergoing chemotherapy: how important is the prevention of opportunistic parasitic infections in patients with malignancies? Parasitol Res. 2017 Sep;116(9):2507-2515. doi: http://dx.doi.org/10.1007/s00436-017-5560-5
9. Bernotienė R, Palinauskas V, Iezhova T, Murauskaitė D, Valkiūnas G. Avian haemosporidian parasites (Haemosporida): a comparative analysis of different polmerase chain reaction assays in detection of mixed infections. Exp Parasitol. 2016 Apr;163:31-7. doi: http://dx.doi.org/10.1016/j.exppara.2016.01.009
10. Chun-Yun L. Investigation on Toxoplasma gondii infections among patients with malignant tumors of the digestive tract in Hainan Province. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019 Sep;31(4):427-430. doi: http://dx.doi.org/10.16250/j.32.1374.2019231
11. Mona IA, Wegdan MAEW, Doaa AH, Hassan A. Toxoplasma gondii in cancer patients receiving chemotherapy: seroprevalence and interferon gamma level. J Parasit Dis. 2019 Sep;43(3):464-471. doi: http://dx.doi.org/10.1007/s12639-019-01111-9
12. Xi-Ming Q, Guo-Qiang S, Xiao-Ming W. Seroepidemiological survey of Toxoplasma gondii infection in patients with gynecological malignant tumors. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2019 Feb;30(6):682-684. doi: http://dx.doi.org/10.16250/j.32.1374.2019036
13. Ngô HM, Zhou Y, Lorenzi H, Wang K, Kim T-K, Zhou Y, et al. Toxoplasma modulates signature pathways of human epilepsy. Sci Rep. 2017;7(1):11496. doi: http://dx.doi.org/10.1038/s41598-017-10675-6
14. Jung B-K, Song H, Kim M-J, Cho J, Shin E-H, Chai J-Y. High Toxoplasma gondii Seropositivity among Brain Tumor Patients in Korea. Korean J Parasitol. 2016 Apr;54(2):201-4. doi: http://dx.doi.org/10.3347/kjp.2016.54.2.201
Information about authors:
Pashinskaya Е.S. – Candidate of Biological Sciences, associate professor of the Chair of Biology & Pharmaceutical Botany, Vitebsk State Order of Peoples’ Friendship Medical University.
Correspondence address: Republic of Belarus, 210009, Vitebsk, 27 Frunze ave., Vitebsk State Order of Peoples’ Friendship Medical University, Chair of Biology & Pharmaceutical Botany. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Еkaterina S. Pashinskaya.
